Deck 64: Aminoglycosides

Question 1

While a patient is receiving an aminoglycoside medication by intramuscular injection,the provider should instruct the patient to expect:

A) discomfort to the injection site, which can be treated with warm moist heat.
B) development of localized infection, which can be treated with an occlusive dressing.
C) discomfort to the injection site, which can best be relieved with narcotic analgesics.
D) development of localized bleeding, which may require the application of an occlusive dressing.

Answer 1

discomfort to the injection site, which can be treated with warm moist heat.

Question 2

A patient who was hospitalized for an infection was treated with an aminoglycoside antibiotic.The patient asks the primary care nurse practitioner (NP)why outpatient treatment wasn't an option.The NP should tell the patient that aminoglycoside antibiotics:

A) are more likely to be toxic.
B) cause serious adverse effects.
C) carry more risk for serious allergic reactions.
D) must be given intramuscularly or intravenously.

Answer 2

must be given intramuscularly or intravenously.

Question 3

A primary care NP sees a patient who was recently hospitalized for infection and treated with gentamicin for 10 days.The patient tells the NP that the drug was discontinued early because "my blood level was too high." The NP should order:

A) a serial audiometric test.
B) a serum blood urea nitrogen (BUN) and creatinine.
C) a urinalysis and complete blood count.
D) serum calcium, magnesium, and sodium.

Answer 3

a serial audiometric test.

Question 4

A patient who was recently hospitalized and treated with gentamicin tells the primary care NP,"My kidney function test was abnormal and they stopped the medication." The patient is worried about long-term effects.The NP should:

A) monitor renal function for several months.
B) reassure the patient that complete recovery should occur.
C) refer the patient to a nephrologist for follow-up evaluation.
D) monitor serum electrolytes and serum creatinine and BUN.